Physician profile
Jonathan Rene
NPI 1861574204
$6,003.12
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2020: $1,408 · 2021: $1,896 · 2022: $1,276 · 2023: $452 · 2024: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $406 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.56 |
| Education | $184.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,762.08 | 2019-2024 | Enbrel, Otezla, Tavneos |
| Janssen Biotech, INC. | $1,397.53 | 2019-2024 | Tremfya |
| Abbvie INC. | $1,310.43 | 2019-2023 | |
| Pfizer INC. | $598.24 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $545.05 | 2020-2022 | |
| Ucb, INC. | $155.98 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $125.57 | 2020-2022 | |
| Lilly USA, LLC | $86.36 | 2019-2021 | |
| Celgene Corporation | $21.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Rene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.